. Author manuscript; available in PMC: 2022 Oct 1.

Published in final edited form as: Sports Med. 2021 Apr 21;51(10):2209–2220. doi: 10.1007/s40279-021-01472-3

Table 3.

Results of the mixed-effects ANOVA for gain to each modality within the recent concussion group between individuals who self-reported that they were diagnosed or treated for headache disorder or migraines and those who self-reported no headache disorder or migraine history.

	Gain to GVS			Gain to Vision			Gain to Vibration

Source	F_1,11	p	Partial η²	F_1,11	p	Partial η²	F_1,11	p	Partial η²

*Vision Migraine**	1.481	.249	.119	.332	.576	.029	.693	.423	.059
*Vibration Migraine**	3.124	.105	.221	2.304	.157	.173
*Vision Vibration * Migraine**	.336	.574	.030	.879	.369	.074
Migraine	.200	.664	.018	.127	.728	.011	.853	.376	.072

	GVS Phase			Vision Phase			Vibration Phase

Source	F_1,11	p	Partial η²	F_1,11	p	Partial η²	F_1,11	p	Partial η²

*Vision Migraine**	1.101	.317	.091	1.914	.194	.148	1.799	.207	.141
*Vibration Migraine**	3.245	.099	.228	.000	.990	.000
*Vision Vibration * Migraine**	3.031	.110	.216	.001	.981	.000
Migraine	.464	.510	.041	3.178	.102	.224	.046	.835	.004

	Residual Power			95% Area			Sway Velocity

Source	F_1,11	p	Partial η²	F_1,11	p	Partial η²	F_1,11	p	Partial η²

*Vision Migraine**	.757	.403	.064	.173	.685	.015	.008	.932	.001
*Vibration Migraine**	.204	.660	.018	.841	.379	.071	1.274	.283	.104
*Vision Vibration * Migraine**	.059	.813	.005	.134	.721	.012	.251	.626	.022
Migraine	.008	.932	.001	.009	.914	.001	.014	.907	.001

Notes: The * indicates statistical significance at adjusted alpha-level, p<.01.